GKOS
GKOS
NYSE · Health Care

Glaukos Corp

$133.52
-0.63 (-0.47%)
As of May 9, 1:15 AM ET ·
Financial Highlights (FY 2026)
Revenue
521.71M
Net Income
-192,968,137
Gross Margin
78.0%
Profit Margin
-37.0%
Rev Growth
+21.5%
D/E Ratio
0.11
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 78.0% 78.0% 35.4% 35.4%
Operating Margin -39.3% -35.4% 19.0% 20.4%
Profit Margin -37.0% -35.1% 13.1% 14.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 521.71M 429.39M 2.07B 2.02B
Gross Profit 406.77M 334.79M 732.67M 713.05M
Operating Income -205,186,977 -151,990,353 394.63M 412.42M
Net Income -192,968,137 -142,939,360 271.54M 285.63M
Gross Margin 78.0% 78.0% 35.4% 35.4%
Operating Margin -39.3% -35.4% 19.0% 20.4%
Profit Margin -37.0% -35.1% 13.1% 14.2%
Rev Growth +21.5% +21.5% +8.3% +18.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 375.89M 375.89M 2.72B 2.42B
Total Equity 3.55B 3.55B 2.33B 2.21B
D/E Ratio 0.11 0.11 1.17 1.09
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -201,828,948 -157,808,642 494.65M 536.96M
Free Cash Flow 145.62M 243.35M